Search
Displaying 41–50 of 1176 results
-
- Sep 9, 2026
- 6:00 p.m. - 8:00 p.m. (EDT)
- 22 Sears St, Burlington, MA 01803
Community EventJoin us for New England Vision Connection
-
- Sep 9, 2026
- 5:30 p.m. - 7:30 p.m. (EDT)
- 200 Kelton Ave, Columbus, OH 43205
Community EventJoin the Foundation Fighting Blindness for Vision Connection, an enriching and supportive gathering across the Foundation Chapter network for the blind and low vision community.
-
- Sep 9, 2026 - Sep 11, 2026
- 5:00 p.m. - 1:00 p.m.
- 10950 N. Torrey Pines Road, La Jolla, CA 92037
Foundation EventThe Foundation Fighting Blindness, together with the Nixon Visions Foundation, invites you to join a free, in-person workshop bringing together individuals and families affected by PRPH2 and associated retinal diseases, along with researchers, physicians, and industry partners.
-
The following list of doctors has been compiled by the Foundation Fighting Blindness for the convenience of patients and families. The accuracy of the list cannot be guaranteed nor should it be construed as an endorsement of any doctor.
-
Eye on the Cure Podcast | Episode 103: Kenyetta McCurdy-Byrd and Heather Edwards
PodcastTwo non-profit professionals talk about plugging into community and finding low-vision resources through the Foundation.
-
First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America
Research NewsCell therapy DSP-3077 is in Phase 1/2a clinical trials
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
Research NewsDeal marks another step as gildeuretinol advances towards patients
-
Jackson's New Discoveries After LUXTURNA
Beacon StoriesAfter receiving LUXTURNA at age 9, Jackson Kennedy began experiencing everyday moments he had never been able to see before—from ice cubes floating in a glass to traffic moving through a city street. Today, Jackson is an honor roll student and dedicated wrestler looking ahead to college, while embracing the possibilities his treatment has helped make possible.
-
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
Research NewsProduct launched in Europe, U.S. approval in progress
-
FDA accepts new drug application, prioritizes review for potential Stargardt treatment
Research NewsBelite Bio’s tinlarebant could become the first-ever approved treatment for Stargardt disease
